Skip to main content

Table 2 Univariate logistic regression analysis reporting odds ratios, 95% confidence intervals and p values of factors possibly associated with risk of receiving  off-label antiretroviral therapy 

From: Off-label use of combined antiretroviral therapy, analysis of data collected by the Italian Register for HIV-1 infection in paediatrics in a large cohort of children

 

Children receiving off-label cART (n/N)

%

OR

95% IC

p-value

Age at last check

 < 2 years

3/10

30.0%

1

  

 ≥ 2 years

47/215

21.9%

1.53

(0.38–6.15)

0.548

Sex

 Males

23/104

22.1%

1

  

 Females

27/121

22.3%

0.988

(0.52–1.85)

0.971

Origin

 Foreign Country

15/91

16.5%

1

  

 Italy

35/134

26.1%

1.791

(0.91–3.51)

0.090

Age at the Beginning of the current regimen

 ≥ 2 years

34/188

18.1%

1

  

 < 2 years

16/37

43.2%

3.24

(1.63–7.30)

0.001

Nr. of previous cART regimens

 < 1

15/45

33.3%

1

  

 1

35/180

19.4%

207

(1.0006–4.26)

0.048

Pre-cART VL*

 Undetectable

13/81

16.0%

1

  

 Detectable

24/76

31.6%

2.414

(1.13–5.19)

0.024

 Missing

13/68

19.1%

1.236

(0.53–2.88)

0.623

VL* at last check

 Undetectable

40/185

21.6%

1

  

 Detectable

10/39

25.6%

1.25

(0.56–2.78)

0.584

 Missing

0/1

0.0%

omitted

  

Pre-cART CD4+ lymphocytes count

 < 15

2/14

14.3%

1

  

 > 15

31/137

22.6%

1.755

(0.37–8.26)

0.477

 Missing

17/74

23.0%

1.789

(0.36–8.79)

0.474

CD4+ lymphocytes percentage at last check

 < 15%

4/8

50.0%

1

  

 > 15%

46/217

21.2%

0.269

(0.06–1.12)

0.071

  1. VL viral load, cART combined antiretroviral therapy